🇺🇸 FDA
Patent

US 9169294

Anti-angiogenic molecules, nanostructures and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 9169294 (Anti-angiogenic molecules, nanostructures and uses thereof) held by Northwestern University expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61P, A61P35/00